Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer
cancer
More to come from PARP drugs, says biotech CEO after striking radiotherapy deal with AZ
Pharmaforum
Thu, 09/5/19 - 10:15 am
AstraZeneca
Theragnostics
PARP inhibitors
diagnostics
cancer
Trying to turn 'natural killers' against cancer, Nkarta raises $114 million
Bizjournals
Thu, 09/5/19 - 10:10 am
Nkarta Therapeutics
IPOs
cancer
natural killer cells
CAR-T
Cancer drugs' share of new FDA approvals doubled this decade thanks to smarter R&D: report
Fierce Pharma
Wed, 09/4/19 - 11:32 pm
cancer
drug approvals
FDA
FDA Finalizes Guidance on Placebos and Blinding for Cancer Trials
RAPS.org
Wed, 08/28/19 - 10:47 pm
FDA
clinical trials
cancer
placebos
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight
Xconomy
Wed, 08/28/19 - 10:55 am
Celgene
cell therapies
drug development
Immatics
cancer
IGM Biosciences files for $100 Million IPO
CP Wire
Tue, 08/20/19 - 09:57 am
IGM Biosciences
IPOs
antibodies
cancer
Many clinical trials for new cancer drugs didn’t include any data on race
Stat
Mon, 08/19/19 - 10:30 am
clinical trials
race
cancer
racial diversity
How Merck Could Ride 'The Keytruda Wave' To Dominate These Rivals
Investors Business Daily
Sat, 08/17/19 - 01:31 pm
Merck
Keytruda
cancer
MD Anderson and Boehringer Ingelheim to Partner on Cancer, Found a Virtual R&D Center
BioSpace
Mon, 08/12/19 - 05:29 pm
Boehringer Ingelheim
MD Anderson Cancer Center
cancer
R&D
AstraZeneca cancer drugs build as primary care shrinks
Biopharma Dive
Mon, 08/12/19 - 12:08 pm
AstraZeneca
cancer
oncology
primary care
Tagrisso
Symbicort
Lynparza
Revealing the true value of new cancer drugs to payers
Pharmaforum
Sat, 08/10/19 - 02:00 pm
CAR-T
cancer
payers
Guardant’s blood test tracks microsatellite instability status on par with tissue biopsy in new study
Fierce Biotech
Mon, 08/5/19 - 10:05 am
Guardant Health
biomarkers
diagnostics
DNA
cancer
solid tumors
Sales gap grows between rival Merck, Bristol cancer therapies
Biopharma Dive
Tue, 07/30/19 - 11:33 am
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
cancer
NEC buys OncoImmunity to boost AI-based cancer research
Pharmaforum
Tue, 07/30/19 - 08:04 am
NEC
M&A
OncoImmunity
artificial intelligence
machine learnings
R&D
cancer
How $2.8B Genomic Health deal catapults Exact beyond Cologuard
BioCentury
Mon, 07/29/19 - 11:21 pm
EXACT Sciences
M&A
Genomic Health
Cologuard
cancer
diagnostics
FDA approves Rituxan biosimilar
Beckers Hospital Review
Tue, 07/23/19 - 07:40 pm
Pfizer
biosimilars
FDA
Ruxience
cancer
autoimmune disease
Genentech
Did cancer clinical trials stay on track at ASCO 2019?
Pharmaforum
Fri, 07/19/19 - 01:00 pm
ASCO
clinical trials
cancer
ASCO 2019
bladder cancer
breast cancer
prostate cancer
pancreatic cancer
Denmark's Genmab hits the jackpot with $500M+ US IPO as smaller biotechs rake in a combined $147M
Endpoints
Thu, 07/18/19 - 10:12 am
Genmab
IPOs
cancer
In a small study, a cancer vaccine assist beats immunotherapy drugs alone
Stat
Mon, 07/15/19 - 10:03 am
cancer vaccines
vaccines
Neon Therapeutics
cancer
metastatic non-small-cell lung cancer
metastatic bladder cancer
immunotherapy
Researchers Find Key Mechanism Behind How Cancer Spreads
BioSpace
Fri, 07/12/19 - 12:12 pm
cancer
mEAK-7
mTOR
metastatic cancer
Pages
« first
‹ previous
…
28
29
30
31
32
33
34
35
36
…
next ›
last »